Moderate to Severe Asthma: Journal Articles
- Effectiveness of mRNA Vaccines Among Children Aged 3-5 Years
- Peripheral Blood Eosinophilia and Asthma Severity
- Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants
- The Influence of COVID-19 Disease on Asthma
- Experience of Super-Responders to Biologics in Severe Asthma
- Astegolimab or Efmarodocokin Alfa in Severe COVID-19
- Infertility, Pregnancy Loss and ART in Women With Asthma
- Real-World Effectiveness of Omalizumab for Severe Asthma
- Is Immunotherapy Safe For Treatment of Severe Asthma
- Dupilumab in Mild to Moderate Asthma Comorbid With CRSwNP
- Antipsychotics Associated With Severe Asthma Exacerbation Risk
- COVID-19 and Pediatric Asthma: Friend or Foe?
- Cost-Utility of Triple vs Dual Inhaler Therapy in Asthma
- Severe Refractory Asthma Treated With Benralizumab
- Optimizing Inhalation Therapy in COPD and Asthma Patients
- The Effect of Curcumin in Moderate to Severe Asthmatics
- Is Asthma a Risk Factor for COVID-19 Worse Outcomes?
- Spontaneous Resolution of Atopic Dermatitis With Benralizumab
- Asthma, SARS-CoV-2 and COVID-19
- Advances in Allergen Immunotherapy for Asthma